Intrinsic value of Fresenius Medical Care AG & Co. KGaA (FMS)

[per Chepakovich valuation model]

other valuations of FMS

[per Chepakovich valuation model]  See other valuations of FMS stock

Previous Close$40.57
Intrinsic Value
Upside potential
Previous Close
$40.57

VALUATION INPUT DATA

Revenue, mln $
Initial revenue growth rate (norm.), %
Variable cost ratio, %
Fixed operating expenses, mln $
Production assets / Revenue, %
Working capital / Revenue, %
Interest rate on debt, %
Life of production assets, yrs
Initial discount rate, %
Shares outstanding, mln
Adjusted equity ratio
Adjusted assets / Revenue
Based on fiscal year data as of 2020-12-31 and quarterly data as of 2020-12-31.
NOTE: The bar chart shows historic and forecasted yearly revenue growth rates. Its purpose is to help you in determining what initial revenue rate you want to base your stock valuation on. Please make sure that you are confident in the value you select - for most stocks it is by far the most important parameter in valuation.
  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2020(a)2021202220232024202520262027202820292030203120322033203420352036203720382039204020412042204320442045

INCOME STATEMENT

Revenue growth rate, %4.2NaN
Revenue, $20400NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m17768NaN
Operating income, $m2632NaN
EBITDA, $m4672NaN
Interest expense (income), $mNaN
Earnings before tax, $m1902NaN
Tax expense, $m572NaN
Net income, $m1330NaN

BALANCE SHEET

Cash and short-term investments, $m1235NaN
Total assets, $m36198NaN
Adjusted assets (=assets-cash), $m34963NaN
Average production assets, $m21502NaN
Working capital, $m1274NaN
Total debt, $m9010NaN
Total liabilities, $m22112NaN
Total equity, $m14086NaN
Debt-to-equity ratio0.640NaN
Adjusted equity ratio0.403NaN

CASH FLOW

Net income, $m1330NaN
Depreciation, amort., depletion, $m2040NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m4836NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-1184NaN
Free cash flow, $m6019NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m1274
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN